FORMULATION AND EVALUATION OF NASAL NIOSOMAL IN SITU GELS OF LORATADINE

Authors

  • Vyshnavi V. Department of Pharmaceutics, Sri Venkateshwara College of Pharmacy and Research centre, Osmania University, Hyderabad, Telangana-500081, India
  • Indira S. Department of Pharmaceutics, Sri Venkateshwara College of Pharmacy and Research centre, Osmania University, Hyderabad, Telangana-500081, India
  • Prathima Srinivas Department of Pharmaceutics, Sri Venkateshwara College of Pharmacy and Research centre, Osmania University, Hyderabad, Telangana-500081, India

Abstract

Loratadine is an antihistaminic drug, used in the treatment of allergic inflammation. Poor bioavailability of the drug from conventional dosage forms is especially attributable to mucociliary clearance and transient residence time. These problems can be reduced by the employment of niosomal in situ gelling system. In situ gelling of niosomal drops was developed to maintain the drug localization for extended period of time. The niosomal in situ gel formulation was transformed into gel once it is instilled into the nasal cavity. Niosomes were formulated using various surfactants (span 20, 40, 60 and 80) in different ratios using thin film hydration technique. Niosomes were evaluated for particle size, drug entrapment efficiency and in-vitro drug release. Niosomes prepared using cholesterol and span 60 in the ratio 1:1 (F3) showed higher entrapment efficiency (94.87%) and in-vitro drug release (59.90%) was optimized. The optimized niosomes were developed into in situ gel (pH induced and thermoreversible). The gels were evaluated for gelling capability, pH, viscosity, drug content and in-vitro drug release. Ex-vivo permeation was performed for optimized in situ gels (G2 and T5). The flux (Jss) and Permeability Coefficient (Kp) was found to be higher for G2. Hence niosomal in situ gelling system may have its potential applications than the conventional nasal formulations and to improve the bioavailability of the drug through its longer residence time and ability to sustain drug release with minimal loss of drug.

Keywords:

Loratadine, Niosomes, Spans, Carbopol, Poloxamer, Sustained release

DOI

https://doi.org/10.25004/IJPSDR.2015.070103

References

1. Reena MP, Kumar A, Pathak K. Thermally Triggered Mucoadhesive In situ Gel of Loratadine: β-Cyclodextrin Complex for Nasal Delivery. AAPS PharmSciTech 2013; 14(1): 412-424.
2. Nagasamy Venkatesh D, Swetha Priyanka V, Tulasi K, Kalyani K, Ali SA, Jilakara H. Proniosomes: A Superior Drug Delivery System. International Journal of Pharmaceutical Sciences and Drug Research 2014; 6(3): 178-182.
3. Chaudhari SP, Bhandurge N, Kolhe SS, Ratnaparkhi MP. Development of Safranal Niosomal In situ Nasal gel formulation. World Journal of Pharmaceutical Research 2013; 2(5): 1685-1703.
4. Lavanya B, Indira S, Srinivas P. Formulation and Evaluation of Ocular Niosomal In situ gels of Linezolid. International Journal of Pharmaceutical Sciences and Research 2014; 5(4): 1367-1375.
5. Kshitij B, Suraj R. Niosome: a Novel Drug Delivery System. Asian Journal of Pharmaceutical Research 2013; 3(1): 16-20.
6. Inayat BP, Vijay C, Irfan F, Prakash S. Formulation, Design and Evaluation of nasal in situ gel as a novel vehicle for Azelastine hydrochloride. International Journal of Drug Delivery 2013; 5: 284-290.
7. Anjan D, Subrata C, Arup M, Jayanta C. Formulation and Development of In situ Gelling System for Nasal Administration for Ondansetron Hydrochloride by Using Pluronic F-127. Journal of Pharmacy and Pharmaceutical Sciences 2013; 2(3): 52-61.
8. Madhavi CP, Pochaiah B, Rao AM. Formulation and Evaluation of Metformin Based Niosomes. International Journal of Pharma Research & Review 2013; 2(1):1-7.
9. Parthibarajan R, Pradeep Kumar S, Gowri Shankar NL, Balakishan L. Design and In-vitro Evaluation of Voriconazole Niosomes. International Journal of Pharmacy and Pharmaceutical Sciences 2013; 5(3), 604-611.
10. Bini KB, Akhilesh D, Prabhakara P, Kamath JV. Development and Characterization of Non-Ionic Surfactant Vesicles (Niosomes) for Oral delivery of Lornoxicam. International Journal of Drug Development & Research 2012; 4(3): 147-154.
11. Jyotivardhan J, Anantvar SP, Narkhede MP, Gore SV, Karvin M. Formulation and Evaluation of Thermoreversible In-Situ Nasal Gel of Metoprolol Succinate. International Journal of Pharmacy and Pharmaceutical Sciences 2012; 4(3):96-102.
12. Dattatraya J, Harish K, Sarika S. Formulation and Evaluation of Thermosensitive In situ gel of Salbutamol Sulphate for Nasal Drug Delivery System. International Journal of Pharmacy and Pharmaceutical Sciences 2012; 4(4): 188-194.
13. Sakthivel M, Kannan K, Manavalan R, Senthamarai R. Formulation and In Vitro Evaluation of Niosomes Containing Oxcarbazepine. International Journal of Pharmacy and Pharmaceutical Sciences 2012; 4(3): 563-567.
14. Madhav NVS, Saini A. Niosomes: A Novel Drug Delivery System. International Journal of Research in Pharmacy and Chemistry 2011; 1(3): 498.
15. Ismail Mouzam MD, Dehghan MHG, Shaikh Samina M, Development and Characterization of Salmeterol Xinafoate Niosomes for Nasal Delivery. Indian Journal of Pharmaceutical Education and Research 2011; 45(2): 121-126.

Published

01-01-2015
Statistics
Abstract Display: 883
PDF Downloads: 784
Dimension Badge

How to Cite

“FORMULATION AND EVALUATION OF NASAL NIOSOMAL IN SITU GELS OF LORATADINE”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 7, no. 1, Jan. 2015, pp. 13-21, https://doi.org/10.25004/IJPSDR.2015.070103.

Issue

Section

Research Article

How to Cite

“FORMULATION AND EVALUATION OF NASAL NIOSOMAL IN SITU GELS OF LORATADINE”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 7, no. 1, Jan. 2015, pp. 13-21, https://doi.org/10.25004/IJPSDR.2015.070103.